Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
09/2003
09/12/2003WO2002009683A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
09/11/2003US20030171364 Phosphodiesterase inhibitor compounds; therapeutic activity as anti-inflammatory and anti-allergic medicinal products, and in the treatment of various respiratory diseases such as asthma
09/10/2003EP1342719A1 Benzodiazepine derivatives useful as CCK-Receptor Antagonists
09/10/2003EP1341793A2 Crf receptor antagonists and methods relating thereto
09/10/2003EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/04/2003WO2003072558A2 Arylsulfone derivatives
09/04/2003US20030166636 Hydroxyalkanoylaminolactams and related structures as inhibitors of A-beta protein production
09/04/2003CA2476173A1 Arylsulfone derivatives
09/03/2003EP0945445B1 1,5-benzodiazepine derivatives
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
09/03/2003CN1440281A Medicine for reducing intraocular pressure
09/02/2003US6613743 Sulfonamide inhibitors of aspartyl protease
08/2003
08/28/2003US20030162965 Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds
08/28/2003US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
08/28/2003US20030162764 Pyrimidine A2b selective antagonist compounds, their synthesis and use
08/28/2003US20030162759 Preventing or treating cardiovascular disease including atherosclerosis
08/27/2003EP1337251A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors
08/26/2003US6610742 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030158224 Vascular endothelial growth factor receptor tyrosine kinases inhibitors; angiogenesis inhibitors, anticarcinogenic agents
08/21/2003US20030158202 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
08/21/2003US20030158082 Chemical process
08/14/2003WO2003031416A3 [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain
08/14/2003US20030153096 For reference standards in immunoassays; drug screening
08/13/2003CN1436175A Cyclic lactams as inhibitors of A beta-protein production
08/13/2003CN1117569C Bicyclic fibrinogen antagonists
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/07/2003US20030149027 1,5-benzodiazepine compounds, their production and use
08/07/2003US20030149020 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149019 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/06/2003CN1434803A Cyclic lactams as inhibitors os A-alpha protein production
08/05/2003CA2087672C 1,5-benzodiazepine derivatives
07/2003
07/31/2003WO2003062819A2 Water- soluble derivatives of lipophilic drugs
07/31/2003WO2003062228A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
07/31/2003WO2003062226A1 Quinazoline(di) ones for invertebrate pest control
07/31/2003CA2473498A1 Water-soluble derivatives of lipophilic drugs
07/30/2003CN1433407A Bis-arylsulfones
07/29/2003US6600036 Treating diseases of the central nervous system.
07/29/2003US6599903 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
07/23/2003EP1329450A1 Benzodiazepine derivative
07/23/2003EP0628033B1 Benzodiazepin derivatives useful as cck-receptor antagonists
07/17/2003US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus
07/17/2003US20030134841 Succinoylamino lactams as inhibitors of A-beta protein production
07/16/2003EP1326857A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonists
07/16/2003EP1326849A1 Benzodiazepine derivatives as inhibitors of gamma secretase
07/16/2003CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1114403C Vitronectin receptor antagonists
07/10/2003US20030130272 Topoisomerase inhibitor; viricides
07/10/2003US20030130271 1,3-Diheterocyclic metalloprotease inhibitors
07/10/2003US20030130256 Stimulant of central nervous system regeneration
07/10/2003US20030130251 Blocking amyloid deposits; Alzheimer's disease, Down syndrome
07/10/2003US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/09/2003EP1325912A1 2,2-diphenylbutanamide derivatives and medicines containing the same
07/09/2003EP1265875A4 Process for preparing pure crystalline lorazepam
07/09/2003EP0937067B1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors
07/09/2003EP0665897B1 Complex combinatorial chemical libraries encoded with tags
07/03/2003WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
07/03/2003US20030125494 Heterocyclic alkoxyamines as regulators in controlled radical polymerization processes
07/02/2003EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
07/01/2003US6586592 Bis-arylsulfones
07/01/2003US6586454 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
06/2003
06/26/2003WO2003051275A2 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003US20030120066 Synthetic peptides
06/26/2003US20030119815 Lactams substituted by cyclic succinates as inhibitors of A-beta protein production
06/26/2003US20030119785 Vitronectin receptor antagonists, their preparation and use
06/26/2003US20030119029 Apoptosis, autoimmune diseases, antiproliferative agents, antiinflammatory agents, anticancer agents
06/26/2003CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof
06/25/2003EP1200442B1 2,3-benzodiazepine derivatives
06/19/2003WO2003050092A2 Process for the preparation of tofisopam and new intermediates
06/19/2003US20030114444 Analgesics
06/19/2003US20030114442 Reducing concentration of blood lipoproteins
06/19/2003US20030114387 Gamma secretase inhibitors
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/17/2003US6579870 5-(1,4-diazepan-1-yl)-2-((3 -fluorophenyl)sulfonyl)phenylamine for example; treatment of diseases or disorders of the central nervous system; modulation of serotonin (5-HT) activity
06/12/2003WO2002009683A9 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
06/12/2003US20030109564 Treating: allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
06/12/2003US20030109524 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists
06/12/2003US20030109518 Substituted 1,4-benzodiazepines and uses thereof
06/11/2003EP1317442A1 Quinolinone derivatives as tyrosine kinase inhibitors
06/11/2003EP1317431A2 Polyarylcarboxamides useful as lipid lowering agents
06/10/2003CA2120020C Air treatment plant for foodstuff comprising a trough with an adjustable width
06/05/2003US20030105102 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting PARP activity
05/2003
05/29/2003US20030100755 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
05/29/2003US20030100512 Gamma-secretase inhibitors
05/28/2003EP1313426A4 Succinoylamino benzodiazepines as inhibitors of a-beta protein production
05/28/2003EP1313426A2 Succinoylamino benzodiazepines as inhibitors of a-beta protein production
05/28/2003EP0973763B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
05/22/2003WO2003041715A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003WO2003041658A2 Process for the preparation of 3,7-disubstituted-2,3,4,5- tetrahydro-1h-1,4-benzodiazepine compounds
05/22/2003US20030096809 Such as (R)-(-)-3-(3-(1-tert-butylcarbonylmethyl-2-oxo-5-cyclohexyl-1,3,4,5 -tetrahydro-2H-1,5-benzodiazepin-3-yl) ureido)benzoate for inhibiting secretion of gastric acid and potent antagonism against gastrin and/or cholecystokinin-B
05/22/2003US20030095958 Inhibiting beta amyloid converting enzyme responsible for A beta peptide cleavage to treat Alzheimer's Disease, Down's Syndrome, etc.
05/22/2003CA2466055A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/20/2003US6565941 Medium for a color changer
05/15/2003WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
05/15/2003US20030092677 Glutamate receptor antagonists
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 60